- Home
- NVS vs GS Comparison
NVS vs GS Comparison
Compare NVS & GS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- GS
- Stock Information
- Founded
- NVS 1895
- GS 1869
- Country
- NVS Switzerland
- GS United States
- Employees
- NVS N/A
- GS N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- GS Investment Bankers/Brokers/Service
- Sector
- NVS Health Care
- GS Finance
- Exchange
- NVS Nasdaq
- GS Nasdaq
- Market Cap
- NVS 230.5B
- GS 187.7B
- IPO Year
- NVS 1991
- GS 1999
- Fundamental
- Price
- NVS $116.18
- GS $640.78
- Analyst Decision
- NVS Hold
- GS Buy
- Analyst Count
- NVS 6
- GS 15
- Target Price
- NVS $123.67
- GS $602.54
- AVG Volume (30 Days)
- NVS 1.3M
- GS 1.8M
- Earning Date
- NVS 07-17-2025
- GS 07-16-2025
- Dividend Yield
- NVS 3.44%
- GS 1.89%
- EPS Growth
- NVS N/A
- GS 68.40
- EPS
- NVS 6.38
- GS 42.98
- Revenue
- NVS $53,222,000,000.00
- GS $53,044,000,000.00
- Revenue This Year
- NVS $7.22
- GS $9.36
- Revenue Next Year
- NVS $1.94
- GS $4.33
- P/E Ratio
- NVS $17.71
- GS $14.78
- Revenue Growth
- NVS 11.50
- GS 13.52
- 52 Week Low
- NVS $96.06
- GS $437.37
- 52 Week High
- NVS $120.92
- GS $672.19
- Technical
- Relative Strength Index (RSI)
- NVS 52.40
- GS 67.79
- Support Level
- NVS $115.55
- GS $609.59
- Resistance Level
- NVS $120.92
- GS $632.27
- Average True Range (ATR)
- NVS 1.09
- GS 10.70
- MACD
- NVS -0.33
- GS 0.76
- Stochastic Oscillator
- NVS 12.94
- GS 96.28
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 14% of its revenue comes from investment banking, 42% from trading, 20% from asset & wealth management, 15% from net interest income, and 9% from other principal transactions. Around 64% of the company's net revenue is generated in the Americas, 13% in Asia, and 23% in Europe, the Middle East, and Africa.